Launch week offerEnds in00h00m00s

annual Promonthly Pro

Marc Ghany

Has grant

Tenure Track Investigator

National Institutes of Health

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Recent Grants

Grant: Close

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B

Open Date: 2009-01-01

Close Date: 2019-01-01

Grant: Close

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C

Open Date: 2009-01-01

Close Date: 2019-01-01

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (10)

Jordan J. Feld

CANADA

View details

Philip Rosenthal

Professor

University of California, San Francisco

UNITED STATES

View details

Anna SF Lok

University of Michigan

UNITED STATES

View details

Arthur Kim

Massachusetts General Hospital

UNITED STATES

View details

David Kleiner

National Cancer Institute

UNITED STATES

View details

Haitao Guo

Professor

University of Pittsburgh

UNITED STATES

View details

Mandana Khalili

Professor of Medicine

University of California, San Francisco

UNITED STATES

View details

Norah A. Terrault

Professor of Medicine

University of Southern California Keck School of Medicine

UNITED STATES

View details

Kyong-Mi Chang

Professor of Medicine & Associate Chief of Staff for R&D

University of Pennsylvania

UNITED STATES

View details

Abdus Wahed

Professor

University of Rochester Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc Ghany

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (16)

AASLD IDSA Practice Guideline on treatment of chronic hepatitis B

Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis B

High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium

HBsAg Loss and Hepatocellular Carcinoma Surveillance: One Size Does Not Fit All

Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal

Autoimmune‐Like Hepatitis Following Hepatic Graft‐Versus‐Host Disease in an Allogenic Hematopoietic Cell Transplant Recipient

Editorial: Clinical Impact of Lipid Profile Change After DAA Treatment in CHC Patients—Authors' Reply

Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB

Reply to: “Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies”

Hepatitis B Vaccine: Four Decades on

Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study

Use of HBV RNA and to predict change in serological status and disease activity in CHB

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy

Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure.

HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy

Collaborators (10)

Jordan J. Feld

Philip Rosenthal

Anna SF Lok

Arthur Kim

David Kleiner

Haitao Guo

Mandana Khalili

Norah A. Terrault

Kyong-Mi Chang

Abdus Wahed

Make your next move.